Search Results 51-60 of 17174 for FMT and Ulcerative Colitis
This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.
This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms, treatment and managing flares.
Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to ...
... ulcerative colitis (UC) who are refractory to or intolerant of TNF inhibitors. Participation eligibility. Participant eligibility includes age, gender, type ...
To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...
The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...
This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and ...
... ulcerative colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.